Company / Current Assets
Biofrontera Inc. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$18.1M
FY2025
5-year range
$18.1M / $46.4M
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 3 consecutive years, from $46M in FY2022 to $18M in FY2025.
Based on SEC 10-K filings.
$18M in FY2025 with a 3-year CAGR of -27.0%.
Declined from $23M to $18M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -27.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Biofrontera Inc.'s current assets has declined for 3 consecutive years.
- 3-year CAGR of -27.0%, indicating a declining trend.
- In FY2025, current assets decreased 12.6% year-over-year.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.1M | -12.6% |
| FY2024 | $20.7M | -10.3% |
| FY2023 | $23.1M | -50.3% |
| FY2022 | $46.4M | +0.0% |
| FY2021 | $46.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026